Skip to main content

ORIGINAL RESEARCH article

Front. Pharmacol. , 30 January 2018

Sec. Inflammation Pharmacology

Volume 9 - 2018 | https://doi.org/10.3389/fphar.2018.00022

RETRACTED: A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5

Updated
\r\nZhi Xin&#x;Zhi Xin1†Cui Jin&#x;Cui Jin1†Liu Chao&#x;Liu Chao2†Zhang ZhengZhang Zheng1Cao Liehu,Cao Liehu3,4Pan Panpan,Pan Panpan3,4Weng Weizong,Weng Weizong3,4Zhai XiaoZhai Xiao3Zhao QingjieZhao Qingjie2Hu HonggangHu Honggang2Qin LongjuanQin Longjuan5Chen Xiao,*Chen Xiao3,4*Su Jiacan,*Su Jiacan3,4*
  • 1Graduate Management Unit, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China
  • 2School of Pharmacy, Second Military Medical University, Shanghai, China
  • 3Department of Orthopedics, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China
  • 4China-South Korea Bioengineering Center, Shanghai, China
  • 5Orthopedic Basic and Translational Research Center, Jiangyin, China

Citation: Xin Z, Jin C, Chao L, Zheng Z, Liehu C, Panpan P, Weizong W, Xiao Z, Qingjie Z, Honggang H, Longjuan Q, Xiao C and Jiacan S (2018) A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5. Front. Pharmacol. 9:22. doi: 10.3389/fphar.2018.00022

Received: 25 July 2017; Accepted: 08 January 2018;
Published: 30 January 2018; Retracted: 19 February 2025.

Edited by:

Patrizia Ballerini, Università degli Studi “G. d’Annunzio” Chieti – Pescara, Italy

Reviewed by:

Satish Ramalingam, SRM University, India
Antonio Recchiuti, Università degli Studi “G. d’Annunzio” Chieti – Pescara, Italy

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

Man ultramarathon runner in the mountains he trains at sunset

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more